2-(4-morpholinoanilino)-6-cyclohexylaminopurine has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlos, JAEG; Coelho-Silva, JL; Costa-Lotufo, LV; de Melo Alves-Paiva, R; de Souza Santos, FP; Hamerschlak, N; Lima, K; Machado-Neto, JA; Moreno, NC; Traina, F; Vicari, HP | 1 |
1 other study(ies) available for 2-(4-morpholinoanilino)-6-cyclohexylaminopurine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.
Topics: Apoptosis; Aurora Kinase B; Autophagy; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Clone Cells; DNA Damage; Humans; Morpholines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purines | 2020 |